TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today that it has appointed Rita Kelley as the Company’s Senior Director of Marketing, a newly created position. A recognized leader in global pharmaceutical and biotechnology marketing, Ms. Kelley will play an integral role in execution of the North American launch and global marketing activities for Ceplene® (histamine dihydrochloride). A New Drug Application (NDA) for Ceplene as remission maintenance therapy in AML was filed with the Food and Drug Administration on June 29, 2010.
